Why the study?
Does dual, basal-rate pump delivery of insulin without preprandial boluses improve HbA1c in insulin-dependent diabetic subjects?
Does dual, basal-rate pump delivery of insulin without preprandial boluses improve HbA1c in insulin-dependent diabetic subjects?
Dual-rate continuous basal insulin infusion without preprandial boluses is an effective and simpler method to achieve glycemic control in insulin-dependent diabetic patients.
This is the authors' abstract. We don't add key points for this paper.
In 11 insulin-dependent diabetic subjects, aged 12-32 yr, we evaluated the efficacy of dual, basal-rate pump delivery of insulin without preprandial boluses. Mean HbA1c fell from 11.6 +/- 3.1% to 7.7 +/- 1.8% at 30 days (P less than 0.005), and remained at 7.1 +/- 1.3% at the time of this evaluation (mean duration of therapy, 6.6 mo). These data suggest that dual-rate continuous basal insulin infusion is an effective means of achieving good diabetes control. Furthermore, it is simpler than the preprandial bolus approach currently used, which may make it suitable for more patients.
May support simplified basal-only pump therapy in insulin-dependent diabetes; leaves open need for randomized confirmation before practice change.
No takes yet. Share an insight, caveat, or question.
Duncan et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: